Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lung Perfusion PET / CT Using Gallium68-MMA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy

NCT04942275 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT04942275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04942275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lung Perfusion PET / CT Using Gallium68-MMA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy
Lead sponsor
University Hospital, Brest
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 15, 2021
Completion date
September 30, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung metastasis, non-small cell lung cancer, sbrt